Exposure to heavy metals, bisphenol A, and phthalates: Implications for precocious or delayed puberty Authors: Seung-Ah Choe, Eunjung Kim, Mina Ha, Li Yang, Li Yang, Li Yang, Li Yang, Li Yang Published: 2025 ABSTRACT This study examined the associations between exposure to heavy metals, bisphenol A (BPA), and phthalates and precocious or delayed puberty. This study was a cross-sectional study using the data obtained from the Korea Environmental Exposure and Health Survey in Children and Adolescents. Blood samples were collected to measure lead, mercury, and cadmium levels, whereas spot urine samples were analyzed for BPA, phthalate metabolites, and creatinine levels. Sexual maturation status was assessed using self-measured Tanner stages. Our analyses involved single- and multi-exposure binomial logistic regression models adjusted for age, body mass index, presence of siblings, urban residence, and socioeconomic status. In the multi-exposure models, we applied quantile g-computation mixture analysis to calculate odds ratios (ORs) for precocious and delayed puberty. In the study cohort of 1,424 individuals, precocious puberty was identified in 50 (3.5%) individuals, whereas delayed puberty was identified in 54 (3.8%) individuals. In the single-exposure models, a higher mono-benzyl phthalate concentration was associated with a higher risk of delayed puberty in girls (OR = 2.75, 95% confidence interval: 1.34, 5.66). In the mixture exposure models, exposure to a mixture of BPA and phthalate metabolites was associated with precocious puberty in boys and delayed puberty in both sexes, although the risk estimates were imprecise. Our findings add to the increasing evidence suggesting that exposure to environmental chemicals may contribute to delayed puberty. Introduction Puberty represents a period of important changes leading to sexual maturation and active reproduction function [1]. It encompasses a spectrum of emotional, hormonal, and physical changes, including the growth of pubic hair (pubarche), alterations in voice pitch, and an increase in height. It also entails breast development (thelarche) and the onset of menstruation (menarche) in girls, and testicular enlargement in boys [2,3]. On average, puberty onset occurs between the ages of 8 and 13 years in girls and between 9 and 14 years in boys [4]. Early- and late-maturing girls and boys face a heightened risk of experiencing elevated depressive symptoms during early adolescence. Individuals who perceive themselves as maturing later in life are more likely to experience body dissatisfaction. Specifically, an earlier onset of menarche is associated with an increased risk of obesity [5], cardiovascular disease [6], reproductive cancers [7], and overall mortality [8]. Puberty onset in children is a multifaceted process influenced by genetic, environmental, and socioeconomic factors. Concerns have arisen regarding the potential impact of environmental pollutants on pubertal development. Among these pollutants, heavy metals, bisphenol A (BPA), and phthalates have garnered considerable attention because of their widespread use in industrial and consumer products and their known or suspected endocrine-disrupting properties. Research has suggested that prenatal exposure to phthalates and BPA is associated with puberty onset in boys and girls. Specifically, higher levels of these chemicals have been linked to delayed puberty in girls and earlier puberty in boys [9–12]. Given the potential health implications of exposure to heavy metals, BPA, and phthalates on pubertal development, there is a pressing need to investigate this association through comprehensive epidemiological studies. Understanding the impact of environmental pollutants on puberty onset is crucial for identifying modifiable risk factors and informing public health interventions aimed at mitigating the adverse outcomes associated with early or delayed puberty. We hypothesized that higher body burdens of endocrine-disrupting chemicals (EDCs)—specifically heavy metals, BPA, and phthalate metabolites—either singly or in combination, would be associated with altered pubertal timing, manifesting as an increased risk of both precocious and delayed puberty, and that these associations would differ by sex. By leveraging data from a national population-based study, we examined the associations between exposure to heavy metals, BPA, and phthalates and puberty onset, highlighting the complex interplay between environmental factors and pubertal development. Methods Study population This study was conducted using the data of Korea Environmental Exposure and Health Survey in Children and Adolescents (KorEHS-C). The survey protocol was performed as previously described [13]. The KorEHS-C is a cross-sectional study based on a nationwide representative sample of 3–18-year-old preschool, elementary-, middle-, and high-school students from 01/03/2012 to 31/10/2014. Among the eligible population, the overall participation rate was 97.5% or 2,388 participants. We excluded those without information on puberty development (n = 529), blood, or urine samples (n = 42). Demographic information was obtained from questionnaires administered to participants and their parents, including questions regarding sociodemographic factors (i.e., household income and each parent’s educational level and occupation) and sexual maturation status (S1 Table). The participants provided blood and urine samples to evaluate their exposure to environmental chemicals and hormones. The study was approved by the Institutional Review Board of Dankook University Hospital, and written informed consent was obtained from the students’ parents or guardians before enrollment (DKUH IRB 2012-01-0010, 2012-10-003-001, 2013-05-004-001, and 2014-06-007-002), and the collected data was anonymized and could not be identified individually. The reuse of the data for this study was approved by the Institutional Review Board (DKUH IRB 2025-02-004-001). Measurement of environmental chemicals The methodology for assessing environmental chemicals was conducted as previously described [13]. Blood and urine samples were collected from the participants on the morning of the survey, between 09:00 am and 11:00 am, following an overnight fasting period. Blood samples were collected using metal-free ethylenediaminetetraacetic acid polyethylene tubes (BD, NJ, USA), and urine samples were collected in 15 mL polystyrene conical tubes (SARSTEDT AG&Co., Numbrecht, Germany). Lead, mercury, and cadmium levels were measured using blood samples. BPA, three metabolites of di(2-ethylehexyl) phthalate, mono-2-ethyl-5-carboxypentyl phthalate [MECPP], mono-2-ethyl-5-hydroxyhexyl phthalate [MEHHP], and mono-2-ethyl-5-oxohexyl phthalate [MEOHP], and a metabolite of di-n-butyl phthalate, mono-n-butyl phthalate [MnBP], and a metabolite of benzyl butyl phthalate, mono-benzyl phthalate [MBzP]), and creatinine levels were measured using spot urine samples. These chemicals were chosen based on similar studies [10,14–18]. The blood samples were stored at ‒20°C. Owing to the low lead and cadmium levels in the blood, triplicate samples were analyzed. Blood samples for mercury were stored at –70°C until analysis. Mercury analysis was conducted using flow injection cold-vapor atomic absorption spectrometry (AAS) (DMA-80; Milestone, Bergamo, Italy). Initially, the samples were dried in an oxygen stream passing through a quartz tube inside a controlled heating coil. The mercury content was then determined using AAS. Laboratory analyses were performed following standardized quality control procedures. The coefficients of variation were 3.6%, 4.2%, and 3.5% in the reference samples for blood lead, cadmium, and mercury, respectively. The urinary BPA levels were measured using high-performance liquid chromatography-tandem mass spectrometry (Agilent 6410 Triple Quad LCMS; Agilent, Santa Clara, CA, USA). Urine aliquots were first adjusted with 30 mL of 2.0 M sodium-acetate buffer (pH 5.0), then fortified with an internal-standard mix containing 100 µg/mL ring-¹³C₁₂-labelled BPA (99%; Cambridge Osotope Laboratories, Andover, MA, USA) and 10 mL of β-glucuronidase/sulfatase (Sigma, St. Louis, MO, USA). Samples were incubated at 37 °C for 3 h to hydrolyze BPA conjugates. After incubation, 100 mL of 2 N HCl was added, the extract was evaporated under nitrogen, and the residue was reconstituted in 1 mL HPLC-grade water inside a 2 mL glass vial. Each analytical batch contained a procedural blank and a quality-control (QC) specimen consisting of pooled urine spiked with 100 ng/mL BPA. Supernatants were cleaned up by solid-phase extraction using Agilent Eclipse, plus C 183.5 mm. Chromatographic separation employed an acetonitrile:water mobile phase (1/4 60:40, v/v) at 0.4 mL/min. Samples for measuring the five phthalate metabolites were stored at –20°C. Monoester phthalates were measured using high-performance liquid chromatography-tandem mass spectrometry (Agilent 6410 Triple Quad LCMS; Agilent, Santa Clara, CA, USA). The between-day coefficient of variation for the assay ranged from 0.5% to 8.9%. For undetected environmental chemicals, the value was replaced with half of the detection limit. The undetected levels ranged from 0% to 6.8% (S2 Table). Identification of precocious and delayed puberty Sexual maturation status was assessed based on self-measured Tanner stages [19]. These self-measured stages of puberty can be used as a valid indicator of sexual development in community-based studies in which physical examination is not feasible [19,20]. Precocious puberty is defined as the appearance of any Tanner stage 2 secondary sexual characteristics before the age of 8 years or menarche before the age of 10 years in girls. For boys, self-reported Tanner stage 2 before the age of 9 years was considered indicative of precocious puberty [21]. Delayed puberty was identified if girls have not reached Tanner stage 2 or experienced menarche by the age of 13 years or if boys have not reached Tanner stage 2 by the age of 14 years [22]. This cross-sectional survey focused on the status of sexual development at the time of assessment. While girls aged 9–13 years were eligible for precocious puberty identification, determining precocious or delayed puberty for boys in this age group was not possible based on the single measurement taken at the time of the survey. Consequently, we could only determine precocious puberty for boys aged ≤8 years and delayed puberty for girls aged ≥13 years and boys aged ≥14 years. After further excluding girls aged < 8 years and boys aged 9–13 years (n = 393), the final study population comprised 1,424 participants (874 girls and 550 boys). Covariates We selected covariates based on a directed acyclic graph and data availability (S3 Fig). The selected covariates included participants’ age at the time of the tests, body mass index (BMI), presence of siblings, urban residence, and socioeconomic status (SES). Age was included as a covariate because it can act as a common cause influencing both chemical exposure and pubertal status [23]. Having siblings may reflect household factors that indirectly influence both exposure and developmental outcomes [24]. We identified those who lived in urban areas (metropolitan or city) based on participants’ home addresses. SES was defined by the higher educational attainment of either parent, and household income exceeding the 2014 median. Parental occupation was excluded from the list of covariates because the non-response rate exceeded 20%. Statistical analysis Descriptive statistics summarized the baseline clinical characteristics of the study sample. Due to their skewness, the levels of all the measured environmental chemicals were log-transformed in regression models. The Spearman correlation test was used to evaluate pairwise associations among the environmental chemicals and to identify strongly correlated compounds. Single-exposure models were used to explore the pairwise association between each chemical and abnormal puberty onset, with separate analyses conducted for girls and boys within the age ranges at risk. Each single-exposure model adjusted for age, BMI, presence of siblings, urban residence, and SES. We calculated the odds ratios (ORs) for precocious and delayed puberty per interquartile range increase in the log-transformed level of each chemical. In the multi-exposure models, we applied quantile g-computation (QGC) mixture analysis to investigate the association of exposure to mixtures of environmental chemicals, adjusting for all covariates listed in the single-exposure models. The QGC approach integrates elements from the weighted quantile sum with the causal inference technique known as g-computation [25]. This methodology is especially beneficial for evaluating the collective impact of multiple environmental factors on health outcomes, with the capacity to reveal nonlinear associations. Compared to most traditional multivariable regression models that suffer from collinearity issues when including multiple correlated variables, QGC method can reduce the impact of extreme correlations between individual exposures by working with quantiles of mixtures rather than the original continuous values [25]. We divided the exposure into two groups: three heavy metals and six chemicals (BPA and five phthalate metabolites). The OR of each chemical mixture associated with a simultaneous one-quartile increase in the mean log-transformed exposure level was estimated using the qgcomp package in R. We provided weights indicating the contribution of the individual components of the mixture to the overall estimate. We further examined a potential interaction by heavy metal exposure in the association between chemical mixture and abnormal puberty. Stratified associations between mixture exposure to phthalate metabolites and abnormal puberty by low (less than median) or high (median or higher) level were assessed for heavy metals which show positive association with abnormal puberty. R (version 4.2.3) was used for all statistical analyses and plots. Results Precocious puberty was identified in 50 (3.5%) participants, and delayed puberty in 54 (3.8%) participants (S1 Table). In both sexes, mean BMI and the proportion with siblings were higher in the delayed-puberty analysis cohort (Table 1). The precocious-puberty cohort had a higher percentage of participants with at least one parent holding a college or university degree. Blood and urinary chemical concentration ranges largely overlapped between the two cohorts. Because the delayed-puberty cohort was older on average, Tanner stages were correspondingly higher. 10.1371/journal.pone.0322383.t001Table 1Participants characteristics of cohorts for analyzing precocious or delayed puberty stratified by sex in the Korea Environmental Exposure and Health Survey in Children and Adolescents (n = 1,424).Variables and chemical levelsGirlsBoysPrecocious puberty cohort (all)Delayed puberty cohort (age ≥ 13)Precocious puberty cohort (age < 9)Delayed puberty cohort (age ≥ 14)N874378166384Age, years (range)12.19 [9.63, 15.15]15.73 [14.17, 16.91]7.74 [7.36, 8.38]16.30 [15.24, 17.37]Body mass index, kg/m219.36 (3.31)21.12 (3.02)16.96 (2.57)22.15 (3.85)Living in urban area304 (34.8)126 (33.3)44 (26.6)138 (35.9)Presence of sibling375 (43.0)187 (49.5)62 (37.3)197 (51.4)Parents with college or university degrees459 (54.1)173 (47.1)100 (61.3)162 (44.0) Heavy metals c Blood lead, ug/dL1.87 [1.44, 2.44]1.84 [1.36, 2.42]1.75 [1.39, 2.15]1.87 [1.41, 2.60] Blood mercury, ug/L1.10 [0.87, 1.39]0.99 [0.76, 1.23]1.38 [1.11, 1.63]1.22 [0.93, 1.48] Urinary cadmium, ug/L creatinine0.29 [0.21, 0.38]0.25 [0.19, 0.33]0.35 [0.27, 0.44]0.21 [0.15, 0.29] Urinary BPA and phthalates metabolites c BPA, ug/g creatinine1.10 [0.58, 2.12]0.76 [0.41, 1.52]1.85 [0.68, 3.81]0.77 [0.46, 1.39] MBzP, ug/g creatinine4.92 [2.63, 10.86]3.71 [2.00, 7.73]8.71 [3.61, 15.82]4.01 [2.16, 8.21] MECPP, ug/g creatinine35.84 [21.66, 58.29]23.64 [15.57, 34.92]68.03 [51.42, 102.69]22.14 [15.57, 31.80] MnBP, ug/g creatinine44.67 [29.95, 72.62]32.09 [23.48, 43.39]78.00 [52.55, 122.77]29.70 [21.17, 40.29] MEOHP, ug/g creatinine17.65 [10.80, 29.90]11.70 [8.19, 17.07]37.27 [27.43, 56.87]11.34 [7.86, 15.95] MEHHP, ug/g creatinine24.05 [14.40, 41.23]16.40 [10.25, 24.72]51.58 [35.10, 75.49]16.39 [11.01, 23.76] Tanner stage Pubic hair I362 (42.3)2 (0.5)133 (82.1)2 (0.5) II162 (18.9)78 (20.8)18 (11.1)16 (4.2) III164 (19.2)140 (37.3)9 (5.6)63 (16.7) IV142 (16.6)130 (34.7)1 (0.6)137 (36.2) V25 (2.9)25 (6.7)1 (0.6)160 (42.3)Breast/Testicular volume I186 (21.8)1 (0.3)93 (56.0)28 (7.3) II155 (18.1)10 (2.7)50 (30.1)69 (18.0) III238 (27.8)128 (34.1)13 (7.8)133 (34.6) IV191 (22.3)156 (41.6)6 (3.6)106 (27.6) V85 (9.9)80 (21.3)0 (0.0)56 (14.6)Urinary levels of cadmium, BPA, and phthalate metabolites were creatinine-adjusted.aP-values for differences among the three groups.bThe median household income for 2014 was used to determine whether income was above the median.cThe values represent median and interquartile range.Abbreviations: SD, standard deviation; BPA, bisphenol A; MBzP, mono-benzyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MnBP, mono-N-butyl phthalate; MEOHP, mono-2-ethyl-5-oxohexyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate. Participants characteristics of cohorts for analyzing precocious or delayed puberty stratified by sex in the Korea Environmental Exposure and Health Survey in Children and Adolescents (n = 1,424). Urinary levels of cadmium, BPA, and phthalate metabolites were creatinine-adjusted. aP-values for differences among the three groups. bThe median household income for 2014 was used to determine whether income was above the median. cThe values represent median and interquartile range. Abbreviations: SD, standard deviation; BPA, bisphenol A; MBzP, mono-benzyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MnBP, mono-N-butyl phthalate; MEOHP, mono-2-ethyl-5-oxohexyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate. In the study population, precocious puberty was more frequent among boys (12 of 166, 7.2%) than girls (38 of 874, 4.3%). Similarly, delayed puberty was observed in 10.9% of boys (42 of 384) and 3.2% of girls (12 of 378). The proportion of participants living in rural areas was higher among those with delayed puberty. The mean levels of cadmium, BPA, and all phthalate metabolites were generally higher in participants with precocious puberty than in those with delayed or normal puberty. The mean cadmium, MECPP, MnBP, MEOHP, and MEHHP levels were higher in the order of delayed, normal, and precocious puberty. Mercury levels did not differ significantly among the three groups. A strong correlation was observed between MECPP and MEOHP (rho = 0.94), MECPP and MEHHP (rho = 0.92), and MEOHP and MEHHP (rho = 0.97; S4 Fig.). For the other pairs, the correlation coefficients ranged from 0.01 to 0.66. In the single-exposure models, the association between the nine measured chemicals and precocious puberty was generally inconsistent across both sexes. Moreover, the confidence intervals (CIs) of the estimates were imprecise when controlling for age, BMI, presence of siblings, urban residence, and SES in girls and boys (Table 2). Among girls, a higher MBzP concentration was associated with a higher risk of delayed puberty (OR = 2.75, 95% CI: 1.34, 5.66). For the other chemicals, the association with delayed puberty did not show significant associations. 10.1371/journal.pone.0322383.t002Table 2Association between levels of heavy metals, BPA, and phthalate metabolites and puberty onset in the single-exposure models in the Korea Environmental Exposure and Health Survey in Children and Adolescents (n = 1,424).ExposureRisk of precocious pubertyRisk of delayed pubertyOR (95% CI)OR (95% CI)GirlsBoysGirlsBoys Log-transformed blood and urinary heavy metals Lead, ug/dL1.54 (0.60, 4.00)0.27 (0.03, 2.18)0.94 (0.20, 4.45)1.50 (0.68, 3.33)Mercury, ug/L1.16 (0.39, 3.48)3.28 (0.47, 23.04)0.42 (0.07, 2.37)2.48 (0.93, 6.56)Cadmium, ug/L creatinine1.23 (0.57, 2.66)0.64 (0.13, 3.02)0.64 (0.15, 2.67)0.91 (0.40, 2.06) Log-transformed urinary levels of BPA and phthalate metabolites BPA, ug/g creatinine1.26 (0.87, 1.82)1.18 (0.65, 2.14)1.35 (0.72, 2.55)1.02 (0.69, 1.50)MBzP, ug/g creatinine1.16 (0.82, 1.64)1.63 (0.92, 2.90)2.75 (1.34, 5.66)1.13 (0.78, 1.64)MECPP, ug/g creatinine1.23 (0.66, 2.30)0.55 (0.17, 1.78)1.12 (0.32, 3.93)1.68 (0.87, 3.24)MnBP, ug/g creatinine0.68 (0.36, 1.31)1.63 (0.52, 5.09)0.86 (0.23, 3.28)1.32 (0.65, 2.68)MEOHP, ug/g creatinine1.10 (0.65, 1.86)0.88 (0.40, 1.93)1.37 (0.43, 4.38)1.48 (0.78, 2.79)MEHHP, ug/g creatinine1.11 (0.66, 1.84)0.89 (0.42, 1.90)1.00 (0.33, 3.04)1.36 (0.75, 2.47)ORs of precocious and delayed puberty per interquartile range increased in the log-transformed level of each chemical in the multiple logistic regression models adjusted for age, body mass index, presence of siblings, urban residence, and socioeconomic status.Abbreviations: OR, odds ratio; CI, confidence interval; BPA, bisphenol A; MBzP, mono-benzyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate; MEOHP; mono-2-ethyl-5-oxohexyl phthalate; MnBP, mono-N-butyl phthalate. Association between levels of heavy metals, BPA, and phthalate metabolites and puberty onset in the single-exposure models in the Korea Environmental Exposure and Health Survey in Children and Adolescents (n = 1,424). ORs of precocious and delayed puberty per interquartile range increased in the log-transformed level of each chemical in the multiple logistic regression models adjusted for age, body mass index, presence of siblings, urban residence, and socioeconomic status. Abbreviations: OR, odds ratio; CI, confidence interval; BPA, bisphenol A; MBzP, mono-benzyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate; MEOHP; mono-2-ethyl-5-oxohexyl phthalate; MnBP, mono-N-butyl phthalate. None of the ORs for the mixture exposure reached statistical significance. The association between the mixture of BPA and phthalate metabolites and precocious puberty was positive in boys (OR = 2.34, 95% CI: 0.36, 15.14; Table 3). The association of heavy metals or a mixture of BPA and phthalate metabolites with precocious puberty was minimal. For delayed puberty, exposure to a mixture of heavy metals (OR = 1.35, 95% CI: 0.80, 2.29) or BPA and phthalate metabolites (1.29, 95% CI: 0.73, 2.31) showed a positive association among boys, whereas the associations with heavy metals, BPA, and phthalate mixture were generally inconsistent among girls. 10.1371/journal.pone.0322383.t003Table 3Association between levels of chemical mixtures and precocious or delayed puberty stratified by sex in the Korea Environmental Exposure and Health Survey in Children and Adolescents (n = 1,424).VariablesGirlsBoysContribution to positive/negative effectPositive/negative coefficientOverall mixture effectOR (95% CI)VariablesContribution to positive/negative effectPositive/negative coefficientOverall mixture effectOR (95% CI)Precocious puberty Heavy metals Heavy metals Blood lead98.7%0.0971.06 (0.62, 1.81)Blood lead100.0%1.0801.29 (0.24, 7.00)Urinary cadmium1.3%Blood mercury78.9%−0.828Blood mercury100.0%−0.038Urinary cadmium21.1% Urinary BPA and phthalate metabolites 1.10 (0.62, 1.95) Urinary levels of BPA and phthalate metabolites 2.34 (0.36, 15.14)MBzP32.2%0.609MBzP25.4%3.520MECPP32.9%MnBP72.0%BPA25.9%BPA2.6%MEHHP9.0%−0.514MECPP62.8%−2.670MnBP66.5%MEHHP5.4%MEOHP33.5%MEOHP31.9%Delayed puberty Heavy metals Heavy metals Blood lead61.9%−0.7310.48 (0.16, 1.45)Blood lead79.6%0.4541.35 (0.80, 2.29)Blood mercury21.3%Blood mercury20.4%Urinary cadmium16.8%Urinary cadmium100.0%−0.151 Urinary levels of BPA and phthalate metabolites 1.33 (0.35, 5.05) Urinary levels of BPA and phthalate metabolites 1.29 (0.73, 2.31)MBzP52.7%2.380MECPP64.8%0.712MEOHP37.1%MnBP20.3%BPA10.2%MBzP14.9%MnBP35.9%−2.100MEHHP41.2%−0.455MECPP35.2%BPA36.9%MEHHP28.9%MEOHP21.9%Quantile g-computation was used to investigate the effects of a chemical mixture of heavy metals, BPA, and phthalate metabolites in a multiple logistic regression model adjusted for age, body mass index, presence of siblings, urban residence, and socioeconomic status. The OR of each chemical mixture for a simultaneous one-quartile change in average chemical exposure was estimated. The contribution of each chemical is presented with the weight (%).Abbreviations: OR, odds ratio; CI, confidence interval; BPA, bisphenol A; MBzP, mono-benzyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate; MEOHP; mono-2-ethyl-5-oxohexyl phthalate; MnBP, mono-N-butyl phthalate. Association between levels of chemical mixtures and precocious or delayed puberty stratified by sex in the Korea Environmental Exposure and Health Survey in Children and Adolescents (n = 1,424). Quantile g-computation was used to investigate the effects of a chemical mixture of heavy metals, BPA, and phthalate metabolites in a multiple logistic regression model adjusted for age, body mass index, presence of siblings, urban residence, and socioeconomic status. The OR of each chemical mixture for a simultaneous one-quartile change in average chemical exposure was estimated. The contribution of each chemical is presented with the weight (%). Abbreviations: OR, odds ratio; CI, confidence interval; BPA, bisphenol A; MBzP, mono-benzyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate; MEOHP; mono-2-ethyl-5-oxohexyl phthalate; MnBP, mono-N-butyl phthalate. For precocious puberty, lead (98.7% for girls and 100.0% for boys) contributed positively to the overall mixture effects of heavy metals, and BPA and phthalate metabolites, respectively. For delayed puberty, however, it was the primary negative contributor to the mixture effect of heavy metals in girls (61.9%), but the primary positive contributor in boys (79.6%). MBzP contributed positively to the overall mixture effect on both abnormal timing of puberty: 32.2% and 25.4% for precocious puberty, and 52.7% and 14.9% for delayed puberty, among girls and boys, respectively. MnBP positively (in boys) or negatively (in girls) contributed to both precocious and delayed puberty. MECCP contributed positively to the mixture effect on precocious puberty in girls and delayed puberty in boys, but negatively to the delayed puberty in girls and precocious puberty in boys. The contribution directions of BPA or other phthalate metabolites are complex by different abnormal puberty or by sex. Stratified associations between mixture exposure to BPA, and phthalate metabolites and abnormal puberty by urinary cadmium level showed similar findings, implicating no significant interaction by the level of heavy metals (S5 Fig). Discussion Our findings reveal a complex relationship between exposure to environmental chemicals and abnormal puberty onset. While the levels of the nine measured chemicals were higher in the order of precocious, normal, and delayed pubertal groups, weak associations were observed between precocious puberty and individual chemicals. A positive association with delayed puberty was observed only for MBzP and solely among girls. Although boys showed an increased risk of precocious and delayed puberty in associations with both mixtures of heavy metals or BPA and phthalate metabolites, the risk estimates were imprecise. These findings offer insights into the potential roles of heavy metals, BPA, and phthalate metabolites in pubertal timing in children and adolescents. Previous studies have yielded conflicting results regarding the link between exposure to various endocrine-disrupting chemicals and puberty onset. For instance, low-level exposure to lead and cadmium has been inversely associated with inhibin B levels, suggesting that these metals may play a role in delaying puberty onset in girls [26]. By employing a cross-sectional design, some studies have replicated the positive association between blood lead and cadmium levels and delayed menarche [15,16,27], whereas others have found that lead and mercury levels are associated with earlier menarche [27,28]. Although the literature on this topic is limited, studies have reported a positive association between heavy metal exposure and delayed puberty in boys [18,29]. This inconsistency may stem from variations in the exposure matrices (blood, urine, or hair) and the definitions used to determine puberty [14,30]. Additionally, our study population comprised children younger than those in previous studies. Specifically, our mixture analyses revealed that exposure to lead predominantly drove the positive association between exposure to a mixture of heavy metals and delayed puberty in boys. This finding supports previous observations of a positive association between heavy metals and delayed puberty. Lead absorbs readily into the bloodstream and accumulates in bone, where it can be remobilized during growth spurts [31]. Because children’s bones are actively remodeling, even moderate lead exposures can translate into sustained internal doses that interfere with developmental processes. Experimental and observational data show that lead can perturb the hypothalamic–pituitary–gonadal (HPG) axis. In animal models, lead exposure delays the rise in luteinizing hormone and slows ovarian follicle maturation; in humans, higher blood lead levels have been associated with later pubertal development in girls [32]. Evidence regarding the effects of BPA exposure and phthalate metabolites during the peripubertal period has been inconclusive. A systematic review reported a positive association between postnatal BPA exposure and earlier thelarche and late pubarche in girls [17]. However, in the same study, postnatal phthalate exposure was not associated with testicular enlargement in boys. In a longitudinal cohort study of Russian boys, MBzP was associated with a slower trajectory of pubertal progression. MBzP is a metabolite of antiandrogenic BzBP, which decreases testosterone production and causes alterations in androgen-organized tissues in a dose-additive manner [33]. Our observation of MBzP as a significant contributor to the association with precocious and delayed puberty was partially aligned with previous findings. An in vivo study found that maternal exposure to butyl benzyl phthalate (the parent compound of MBzP) increased the incidence of undescended testes in rat fetuses [34]. Despite these observations, the association between heavy metals or a mixture of BPA and phthalate metabolites and precocious or delayed puberty appeared minimal in our study cohort. This finding suggests that the mechanisms underlying the effects of environmental chemical exposure on pubertal timing may differ in the context of joint or concurrent exposure. For example, the positive association between phthalate exposure and delayed puberty was stronger in obese boys [35,36]. This may explain the weaker association among the boys of our study population who show generally low BMI. By quantifying joint exposures, our approach enhances comparability with prior small or single-chemical studies. Additionally, participants living in rural areas were more likely to experience delayed puberty. Previous studies have reported that the risk of early menarche increases with a higher regional deprivation index and urbanization [24]. Urbanization is associated with a higher risk of childhood overweight and obesity, which can lead to early puberty [37,38]. Children living in rural areas are less likely to be exposed to hazardous environments, including air pollution and contaminated water, which are associated with precocious puberty [39]. Unfavorable environmental features of urban areas such as limited recreational facilities, poor safety, and high pollution were consistently associated with early menarche among girls [40]. Given the higher risk of early puberty in urban areas, the proportion of individuals with delayed puberty would have been relatively higher in rural areas. This study has several limitations that warrant consideration. First, the sample size might have limited our ability to detect associations with precocious puberty, given its rarity. Assuming a one-quartile increase in exposure confers a 1.5-fold higher risk of precocious puberty, our observed incidence yields only about 60% power. Moreover, with few events relative to the number of exposure variables, there is an elevated risk of model overfitting, imprecision of effect estimates and reduced robustness of the findings. Reliance on a single dataset may magnify these issues, underscoring the need for larger samples and independent replication in future studies to ensure robustness. Nevertheless, as an exploratory study of environmental chemical mixtures, our results can guide future sample-size calculations needed to robustly detect such effects. Pooled or longitudinal study including a large sample would be required for confirmatory inference on multi-exposure associations. Second, only nine chemicals were measured; Unmeasured environmental, nutritional, or genetic factors may remain as potential sources of residual confounding effect. Third, this study did not capture the timing or duration of exposure to environmental chemicals throughout the critical periods of pubertal development, particularly concerning heavy metals with long metabolic half-lives. This might have affected our results and needs to be considered for balanced interpretation of our findings. Fourth, the assessment of pubertal timing relies on a combination of self-reporting and physical examination, which introduces the potential for measurement errors or misclassification of pubertal stages, especially in younger participants. However, given the prevalence of abnormal puberty timing is comparable to prior studies, we believe the potential measurement bias would have been minimal. In addition, our measurement of precocious puberty lacks the detailed timing information needed to support a dose–response analysis. Lastly, although the KorEHS-C data are a representative sample of Korean children and adolescents aged 6–18 years, excluding boys aged 9–13 years in the present study undermines this representativeness. This aspect may limit the generalizability of our findings to a broader population of children and adolescents. The imprecision of risk estimates, particularly for associations with precocious puberty, underscores the need for caution in interpreting these results. Although the risk estimates were imprecise, effect sizes among girls were generally small, suggesting any association between chemical mixtures and abnormal puberty in this group is likely negligible. In boys, despite wide confidence intervals, the consistently positive direction of the estimates indicates a possible link between chemical exposure and abnormal puberty. Given the limited research on the association between multiple chemical exposures and early puberty, our exploratory analysis may serve as a starting point to stimulate further investigation. Finally, the cross-sectional design of this study restricts our ability to establish temporal relationships or infer causality between environmental chemical exposure and pubertal timing. Nonetheless, by including boys and girls and examining precocious and delayed puberty, our analysis offers a comprehensive understanding of how environmental chemical exposure affects pubertal timing across sexes and the spectrum of abnormal puberty. Moreover, we conducted single- and joint-exposure analyses to provide new evidence on the role of chemicals in delayed puberty, an area that has been less studied in environmental epidemiology. Conclusions Our findings contribute to the growing body of evidence implicating the potential role of heavy metals, BPA and phthalate metabolites in pubertal development. Further longitudinal studies with larger sample sizes are needed to elucidate causal relationships and underlying mechanisms driving these associations. Supporting information Characteristics of study participants of the KorEHS-C (n = 1,424). (PDF) Number of samples below the limit of detection of measurement. (PDF) Directed acyclic graph for the causal pathway. (PDF) Pairwise correlation structure of all measured chemicals. (PDF) Stratified association between mixture exposure to BPA, and phthalate metabolites and abnormal puberty. (PDF) 23 Apr 2025 Dear Dr. Ha, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Li Yang, M.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: No Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** Reviewer #1: The manuscript titled 'Exposure to heavy metals, bisphenol A, and phthalates: Implications for precocious or delayed puberty' is interesting and written well. I have only a few remarks: Comment 1: In introduction, the author needs to put forward the hypothesis of this study and clarify the content and significance of his own research. In addition, What are the differences or innovations between this study and these findings? Comment 2: In line 128-129, the authors need to add detailed test procedures or add references. Comment 3: In table 1, need to label units, especially in Blood and urinary measurement of heavy metals, like table 2. Comment 4: In results, it is suggested to add the corresponding figures, here are all tables. In addition, is there any correlation analysis that can be done between these data? Comment 5: in discussion, it is suggested that the authors further enhance the depth of the discussion section of this paper. Reviewer #2: The manuscript has several major shortcomings that impact its overall scientific rigor. The abstract (lines 38–54) does not clearly highlight the cross-sectional nature of the study, which significantly limits any causal interpretation between exposure to environmental chemicals and puberty outcomes. The reliance on self-assessed Tanner stages (line 43) introduces potential bias due to misclassification, especially among younger participants who may lack the ability to accurately evaluate their developmental stage. Although the study employs mixture models (lines 45–46), the results are frequently described as imprecise (lines 52–53, 260), suggesting that the findings may lack robustness and could be due to chance. Among the nine chemicals measured, only mono-benzyl phthalate (MBzP) showed a statistically significant association with delayed puberty in girls (lines 49–51, 259), while associations for other chemicals were weak and inconsistent, particularly in boys. The analysis lacks a detailed discussion of dose-response relationships, which is critical for establishing the biological plausibility of the reported associations. The paper reviews inconsistent findings from previous literature (lines 265–275) but does not adequately explain how the current study design resolves these inconsistencies or adds clarity. The identification of lead as a key driver of delayed puberty in mixture analysis (lines 276–278) is not thoroughly validated by sex-specific or stratified analyses, weakening the strength of the conclusion. The number of identified cases of precocious and delayed puberty is relatively small (lines 47–48), raising concerns about the statistical power of the study and the reliability of the regression models used. These issues collectively limit the interpretability and generalizability of the study’s findings. Reviewer #3: Here is a list of specific comments. Note: line and page numbering in reviews and comments is based on ruler applied in Editorial Manager-generated PDF. 1. Page 3, line 48: There might be issues due to the small number of events per variable in the models, especially the multi-exposure models. The first limitation in the Discussion section addressed the low power issue. I suggest expanding the limitation to other issues such as overfitting, biased estimation, model instability, etc. 2. Page 5, lines 91–92: I suggest reporting the number of participants excluded due to missing information on pubertal development, missing blood samples, and missing urine samples separately. 3. Page 7, lines 135–145: It might be worth considering two separate cohorts, one for the precocious puberty and the other for the delayed puberty. The precocious puberty cohort would consist of girls with age 10 years or younger and boys with age 8 or younger. The delayed puberty cohort would consist of girls with age 13 or older and boys with age 14 or older. In other words, Table S1 would be split into two tables. 4. Page 7, lines 148–150: I suggest rewriting the sentence as follows. ‘The selected covariates included participants’ age at the time of the tests, body mass index (BMI), presence of siblings, urban residence, and socioeconomic status (SES).’ 5. Page 7, line 150: BMI is a well-known metric and does not require a definition. If you would like to keep the sentence, I suggest revising the sentence as ‘BMI was calculated as weight in kilograms divided by height in meters squared.’ 6. Page 7, lines 153–154: I suggest revising “the median” as ‘the median household income for 2014’ and removing the subsequent sentence, “the median household income for 2014 was . . . .” I suggest being specific about the median household income for 2014. 7. Page 7, lines 157–158: I suggest rewriting the sentence as follows. ‘Descriptive statistics summarized the baseline clinical characteristics of the study sample.’ 8. Page 8, lines 158–159: I suggest rewriting the sentence as follows. ‘Due to their skewness, the urine levels of the measured environmental chemicals were log-transformed in regression models.’ 9. Page 8, lines 159–160: I suggest stating the purpose of examining the correlations among the environmental chemicals. 10. Page 8, lines 161–162: I suggest revising the sentence as ‘each single-exposure model adjusted for age, BMI, presence of siblings, urban residence, and SES,’ and relocating the revised sentence to line 165 (after the next sentence). 11. Page 8, line 163: I suggest unifying the use of “environmental chemicals” and “heavy metals, BPA, or phthalate metabolites.” 12. Page 8, line 166: The two blood chemicals, Pb and Hg, were not log-transformed. The phrase was not applicable to all chemicals. 13. Page 8, line 169: I suggest revising “all covariates” as ‘all covariates listed in the single-exposure models.’ 14. Page 8, lines 174–175: Please clarify if it was the one-quartile change in average chemical exposure or in average ‘log’ chemical exposure because the urine levels were log-transformed. 15. Page 8, line 180: There was no Table S3. Did you mean Table S1? 16. Table 1: I suggest not reporting characteristics by the outcome status. I suggest replacing the current Table 1 with Table S1 (after revision). 17. Figure 1: For the same reason as Comment 16 above, I suggest removing Figure 1. 18. Page 10, lines 209–210: Following Comment 9 above, what was the implication of these observed high correlations? If the purpose of reporting correlations was to avoid collinearity, these high correlations might distort the estimates of the multi-exposure models. 19. Table 2: I suggest providing a better indication of which exposures were log-transformed. 20. Table S1: Different age categories in girls and boys made the distributions difficult to interpret. Please consider the two-cohort approach suggested in Comment 3 above. 21. Figure S3: I suggest clarifying what EDC stands for. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. Submitted filename: PONE-D-25-12742_reviewer.docx 4 Jun 2025 We revised the section of data and code availability according the Journal Policy. We also responded to each point of comments of editor and all reviewers. Please find the uploaded response letter. Submitted filename: Response to reviewer_R1.1.docx 29 Jun 2025 Dear Dr. Ha, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Major concerns: 1. Statistical power and model reliability: The number of cases of precocious puberty (50 cases) and delayed puberty (54 cases) is too low. Especially, the exposure model includes 9 chemicals, which may lead to overfitting of the model and unstable estimates (e.g., OR for boys with precocious puberty = 2.34, 95% CI: 0.36 - 15.14). The authors mentioned that the test power is only about 60% (assuming OR = 1.5), but did not fully discuss its potential impact on negative results (such as the possibility that no association with other chemicals may be due to insufficient power). I think the discussion section needs to be expanded to clearly explain the impact of small sample size on the mixed model (such as the risk of overfitting) and suggest the required sample size for future studies. Add sensitivity analysis and add model stability tests (such as Bootstrap method to verify the confidence interval of OR). 2. Limitations of exposure assessment: Relying solely on a single biological sample (blood/urine) cannot reflect the dynamic of long-term exposure, especially for heavy metals with long half-lives (such as lead accumulation in bones). Other environmental pollutants (such as pesticides, flame retardants) were not included, which may miss important confounding factors. The authors need to strengthen the discussion and clearly state the limitations of single measurement in the "Limitations" section. It is recommended that future studies adopt a longitudinal design or cumulative exposure indicators. Supplementary analysis: If the data permit, analyze the interactions between chemical substances (such as heavy metals and phthalates). 3. Rigor of result interpretation: Only MBzP showed a significant effect on girls' delayed puberty (OR = 2.75), while the other associations were not significant or had wide confidence intervals. However, the conclusion that "chemical mixtures are associated with delayed puberty" may be an overinterpretation. The discussion on the mechanism of urban-rural differences (with a higher proportion of girls experiencing delayed puberty in rural areas) is insufficient (such as whether it is related to pollutant exposure levels or social economic factors?). Please revise the conclusion statement to avoid suggesting a "wide correlation of mixtures", and focus on the significance of MBzP and the potential role of lead in boys. Delve deeper into the differences between urban and rural areas, and supplement with literature support (such as citing Oh et al. 2024's discussion on air pollution and precocious puberty). Distinguish the effects of pollution exposure from those of confounding factors such as obesity. 4. Methodological details and data accuracy: In Table 3, "MBaP" should be "MBzP" (Page 21). Inconsistent ethical approval numbers: The main text states 2013-05-004-001 (Page 12), but the supplementary material is 2013-05-004_(III).pdf (Page 38). The correlation coefficients are extremely high (such as MEOHP-MEHHP, ρ=0.97) and the impact of multicollinearity on the model has not been discussed. The authors should correct the data errors, unify the ethical approval numbers, and correct "MBaP" in Table 3. Provide an explanation for handling multicollinearity, clearly explain how QGC reduces the influence of multicollinearity (such as quantile transformation), or provide a VIF analysis in the supplementary material. Minor concerns: 1. Chart optimization: Table 1: Add units (such as blood lead μg/dL) and provide a footnote stating "median [IQR]" or "mean (SD)". Figure S4: Simplify the correlation coefficient graph, highlighting the high correlations with |ρ| > 0.7. 2. Discussion Extension: Analyze the potential mechanisms underlying the significant effect of MBzP in girls and the lack of such effect in boys (such as differences in sex hormone pathways). Refer to the latest literature to support the discussion on the urban-rural disparity. 3. Terminology Consistency: The term "phthalate metabolites" (instead of "phthalates") is uniformly used throughout the text to avoid confusion between the parent compound and its metabolites. ============================== Please submit your revised manuscript by Aug 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Li Yang, M.D. Academic Editor PLOS ONE Additional Editor Comments: Please further address editor comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes ********** Reviewer #1: (No Response) Reviewer #3: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. 5 Aug 2025 Dear Editor Thank you for reviewing our manuscript and for the constructive comments. Below we addressed each point. We will look forward to your feedback. Major Concerns Comment #1: Statistical power and model reliability: The number of cases of precocious puberty (50 cases) and delayed puberty (54 cases) is too low. Especially, the exposure model includes 9 chemicals, which may lead to overfitting of the model and unstable estimates (e.g., OR for boys with precocious puberty = 2.34, 95% CI: 0.36 - 15.14). The authors mentioned that the test power is only about 60% (assuming OR = 1.5), but did not fully discuss its potential impact on negative results (such as the possibility that no association with other chemicals may be due to insufficient power). I think the discussion section needs to be expanded to clearly explain the impact of small sample size on the mixed model (such as the risk of overfitting) and suggest the required sample size for future studies. Add sensitivity analysis and add model stability tests (such as Bootstrap method to verify the confidence interval of OR). Response #1: We appreciate the editor’s comments. We have expanded the Discussion section to acknowledge the potential risk of overfitting and unstable estimates in our nine-chemical mixture model (Lines 301-317). However, given the limited research on the association between multiple chemical exposures and early puberty, our exploratory analysis may serve as a starting point to stimulate further investigation in this area (Lines 317-319, p.17). Comment #2: Limitations of exposure assessment: Relying solely on a single biological sample (blood/urine) cannot reflect the dynamic of long-term exposure, especially for heavy metals with long half-lives (such as lead accumulation in bones). Other environmental pollutants (such as pesticides, flame retardants) were not included, which may miss important confounding factors. The authors need to strengthen the discussion and clearly state the limitations of single measurement in the "Limitations" section. It is recommended that future studies adopt a longitudinal design or cumulative exposure indicators. Supplementary analysis: If the data permit, analyze the interactions between chemical substances (such as heavy metals and phthalates). Response #2: We clearly have addressed that single blood/urine measurements may not capture long‑term exposure and that additional pollutants were not assessed, potentially leaving residual confounding. We therefore recommended future longitudinal designs or cumulative exposure biomarkers. To address the potential interaction by heavy metal exposure, we assessed stratified associations between mixture exposure to BPA, and phthalate metabolites and abnormal puberty by low (less than median) or high (median or higher) urinary cadmium level. The additional findings are described in our manuscript (Lines 164-167 & 226-228; S5 Figure). Comment #3: Rigor of result interpretation: Only MBzP showed a significant effect on girls' delayed puberty (OR = 2.75), while the other associations were not significant or had wide confidence intervals. However, the conclusion that "chemical mixtures are associated with delayed puberty" may be an overinterpretation. The discussion on the mechanism of urban-rural differences (with a higher proportion of girls experiencing delayed puberty in rural areas) is insufficient (such as whether it is related to pollutant exposure levels or social economic factors?). Please revise the conclusion statement to avoid suggesting a "wide correlation of mixtures", and focus on the significance of MBzP and the potential role of lead in boys. Delve deeper into the differences between urban and rural areas, and supplement with literature support (such as citing Oh et al. 2024's discussion on air pollution and precocious puberty). Distinguish the effects of pollution exposure from those of confounding factors such as obesity. Response #3: We have revised our discussion to focus on the robust MBzP association with girls’ delayed puberty and the suggestive lead effect in boys, removing any language implying a positive mixture effect (Line 241-243, p.14). The discussion in our revised manuscript explores urban–rural differences in more depth, with additional citation of similar findings (Line 287-289, p.15-16). According to our conceptual pathway explaining the association between chemical mixture exposure and puberty timing, urban residence and obesity could be separate confounders. Comment #4: Methodological details and data accuracy: In Table 3, "MBaP" should be "MBzP" (Page 21). Inconsistent ethical approval numbers: The main text states 2013-05-004-001 (Page 12), but the supplementary material is 2013-05-004_(III).pdf (Page 38). The correlation coefficients are extremely high (such as MEOHP-MEHHP, ρ=0.97) and the impact of multicollinearity on the model has not been discussed. The authors should correct the data errors, unify the ethical approval numbers, and correct "MBaP" in Table 3. Provide an explanation for handling multicollinearity, clearly explain how QGC reduces the influence of multicollinearity (such as quantile transformation), or provide a VIF analysis in the supplementary material. Response #4: We corrected typos in the manuscript. The ethical‑approval number is consistently listed as 2013‑05‑004‑001. You can check the same number at the ethical approval report by opening the file. However, the number shown in the file name in the supplementary data is missing the trailing "001". Compared to most traditional multivariable linear regression models that suffer from collinearity issues when including multiple correlated variables, QGC method can reduce the impact of extreme correlations between individual exposures by working with quantiles of mixtures rather than the original continuous values (Lines 156-158, p.7). In addition, QGC estimates a single overall effect (psi) for a simultaneous one-quantile increase in all exposures, rather than separate β-coefficients for each original exposure. Because we do not interpret or report separate parameter estimates that could be inflated by collinearity, the VIF is neither meaningful nor necessary (Keil AP, Buckley JP, O'Brien KM, Ferguson KK, Zhao S, White AJ. A Quantile-Based g-Computation Approach to Addressing the Effects of Exposure Mixtures. Environ Health Perspect. 2020;128(4):47004.). Minor Concerns Comment #1: Chart optimization: Table 1: Add units (such as blood lead μg/dL) and provide a footnote stating "median [IQR]" or "mean (SD)". Figure S4: Simplify the correlation coefficient graph, highlighting the high correlations with |ρ| > 0.7. Response #1: In Table 1 we added units (e.g., blood lead μg/dL; urinary phthalates μg/g creatinine) and footnotes indicating “median [IQR]”(Table 1). Figure S4 has been revised to highlight only correlations |ρ|>0.7 (S4 Figure). Comment #2: Discussion Extension: Analyze the potential mechanisms underlying the significant effect of MBzP in girls and the lack of such effect in boys (such as differences in sex hormone pathways). Refer to the latest literature to support the discussion on the urban-rural disparity. Reponse #2: We added discussion of why the association between MBzP and abnormal puberty was not evident in boys of our study population. Because the positive association between phthalate exposure and delayed puberty was stronger in obese boys. This may explain the weaker association among the boys of our study population who show generally low BMI. We additionally cited a recent related literature (Lines 278-280, p.15). Comment #3: Terminology Consistency: The term "phthalate metabolites" (instead of "phthalates") is uniformly used throughout the text to avoid confusion between the parent compound and its metabolites. Response #3: We have reviewed the paper thoroughly and ensured all instances of “phthalates” mean the exposure, not the urinary biomarkers, to clarify we measured metabolites rather than parent compounds. Submitted filename: R2_Response letter_v2.docx 29 Oct 2025 Dear Dr. Ha, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Li Yang, M.D. Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Thanks for submitting your revised paper to PLOS ONE. Your manuscript has now been assessed by our editorial team and external peer experts. Although the study is of potential significance, some additional problems were proposed. Please further address the reviewers' concerns. [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author Reviewer #4: All comments have been addressed Reviewer #5: All comments have been addressed Reviewer #6: (No Response) Reviewer #7: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Partly Reviewer #5: Partly Reviewer #6: Yes Reviewer #7: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: No Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes Reviewer #5: (No Response) Reviewer #6: (No Response) Reviewer #7: Yes ********** Reviewer #4: The present study includes an overall adequate sample size and has applied sound analytical methods. However, the way results are presented, together with certain limitations—some of which were already acknowledged in the manuscript—makes the findings less interpretable and difficult to draw valid inferences from: The sample size in the groups with precocious or delayed puberty is very small, especially when analyses are stratified by sex. There were 50 children with precocious puberty (38 girls and 12 boys) and 54 children with delayed puberty, of whom only 12 were girls. This limited subgroup size substantially reduces the robustness of the statistical analyses. Regarding the inclusion of “having siblings” in the DAG, the rationale for its relationship with the level of exposure to heavy metals, is unclear. Further clarification is needed on how this variable may confound or mediate the associations under study. Among boys, because pubertal status was defined based on the current questionnaire, boys aged 9–13 years were excluded from the study. However, a similar exclusion was not applied to the girls. The justification for this difference between sexes is not provided. The manuscript reports that 874 girls were included in the study, yet Table 1 indicates that 771 girls were included in the total cohort and 387 in the delayed puberty cohort. This discrepancy needs to be clarified. In lines 184–188, the authors make comparisons that are statistically invalid. For example, they state that more girls were in the precocious puberty group (38 of 50). Since the number of boys and girls in the cohort is not equal, such a comparison is not appropriate. Instead, the correct approach would be to compare the proportion of children experiencing precocious puberty within each sex cohort (i.e., the percentage of girls versus the percentage of boys) The definition of precocious and delayed puberty in your study is inherently age-dependent, as early puberty is only detectable in younger children and delayed puberty only in older children. Consequently, age is strongly collinear with the outcome. Entering age directly into the regression model may therefore lead to problems such as overadjustment or complete separation, making the estimates unstable or difficult to interpret. A more appropriate strategy would be to restrict the analysis to an age window where both exposed and unexposed children with and without the outcome are observed or.. Reviewer #5: "Our findings contribute to the growing body of evidence implicating environmental chemicals that have lifelong health impacts on pubertal development." The current study did not focus on all the environmental chemicals so it should be recommended not to say environmental chemicals rather sharing in a more specific way regarding heavy metals and other chemicals included in the study. Longitudinal study should be needed to say the lifelong impact. Reviewer #6: The author has addressed the reviewers' comments, implemented appropriate revisions, and incorporated additional content that enhances the overall completeness and scholarly rigor of the manuscript. The study demonstrates a degree of innovation and holds academic significance within the relevant field. It is therefore recommended for acceptance. Reviewer #7: Using data from the Korea Environmental Exposure and Health Survey in Children and Adolescents, the authors conducted a cross-sectional study to look at the associations between exposure to heavy metals, bisphenol A, and phthalates and precocious or delayed puberty. The authors reported that a higher mono-benzyl phthalate concentration was associated with a higher risk of delayed puberty in girls in single-exposure models, concluding that exposure to environmental chemicals may contribute to delayed puberty. Overall, if the research questions examined in this study were to be replicated in numerous robust studies, the findings could inform public health interventions aimed at reducing the impact of modifiable environmental pollutants on puberty. With that in mind, this reviewer has the following to remark: 1. The authors have made substantial modifications to their manuscript, improving clarity and overall quality. This is evident from the detailed feedback provided by the editor and reviewers. 2. However, a major concern with this study is statistical power. When interpreting the results, it’s crucial to assess whether statistical power was sufficient to detect at least moderate-effect sizes to answer the research questions raised. While the authors, as recommended by the editor, have acknowledged the potential risks of overfitting and unstable estimates in their multi-exposure model, the paper could guide future studies on how to proceed. In their discussion section, the authors could suggest strategies, apart from increasing the sample size (which is a given), to improve the likelihood of detecting a true effect, if one exists. I hope this review is helpful and wish the authors the very best with their research! ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: Yes: Mohammad Aghaali Reviewer #5: Yes: Muhammed Ashraful Alam Reviewer #6: No Reviewer #7: Yes: Dr. Widad Akreyi ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. Submitted filename: Comments.docx 8 Nov 2025 Dear Editor We appreciate the reviewer’s comments. Please find our point-by-point responses and revised manuscript. We will look forward to your feedback. Best regards, Comment #1: The present study includes an overall adequate sample size and has applied sound analytical methods. However, the way results are presented, together with certain limitations—some of which were already acknowledged in the manuscript—makes the findings less interpretable and difficult to draw valid inferences from: The sample size in the groups with precocious or delayed puberty is very small, especially when analyses are stratified by sex. There were 50 children with precocious puberty (38 girls and 12 boys) and 54 children with delayed puberty, of whom only 12 were girls. This limited subgroup size substantially reduces the robustness of the statistical analyses. Response #1: We appreciate the reviewer’s comments. We agree that the subgroup sizes were small, especially for boys with precocious puberty and girls with delayed puberty. We have addressed an explicit acknowledgment of limited power (about 60%), and emphasized that the study is exploratory, aiming to provide effect-size estimates to inform future longitudinal or pooled analyses (Lines 300-301; 304-305, p.16; 324-326, p.17 in the revised manuscript). Comment #2: Regarding the inclusion of “having siblings” in the DAG, the rationale for its relationship with the level of exposure to heavy metals, is unclear. Further clarification is needed on how this variable may confound or mediate the associations under study. Response #2: Having siblings can reflect differences in household characteristics that may indirectly influence both exposure levels and developmental outcomes. Including this variable helps to partially control unmeasured household-level confounding (Lines 140-142, p.6-7). Comment #3: Among boys, because pubertal status was defined based on the current questionnaire, boys aged 9–13 years were excluded from the study. However, a similar exclusion was not applied to the girls. The justification for this difference between sexes is not provided. Response #3: The exclusion of boys aged 9–13 years was based on the definition of precocious and delayed puberty using Tanner stage criteria. While girls in this age group were eligible for precocious puberty identification, determining precocious or delayed puberty for boys aged 9–13 years was not possible based on the single measurement taken at the time of the survey. This issue was addressed in Method (Line 130-132, p.6). Comment #4: The manuscript reports that 874 girls were included in the study, yet Table 1 indicates that 771 girls were included in the total cohort and 387 in the delayed puberty cohort. This discrepancy needs to be clarified. Response #4: Thanks to the reviewer, we corrected the number in Table 1. The total number of girls included in the analysis of precocious puberty was 874 (Table 1). Comment #5: In lines 184–188, the authors make comparisons that are statistically invalid. For example, they state that more girls were in the precocious puberty group (38 of 50). Since the number of boys and girls in the cohort is not equal, such a comparison is not appropriate. Instead, the correct approach would be to compare the proportion of children experiencing precocious puberty within each sex cohort (i.e., the percentage of girls versus the percentage of boys) Response #5: We agree with the reviewer and have revised the text, presenting the percentage of girls versus the percentage of boys (Lines 189-191, p.9). Comment #6: The definition of precocious and delayed puberty in your study is inherently age-dependent, as early puberty is only detectable in younger children and delayed puberty only in older children. Consequently, age is strongly collinear with the outcome. Entering age directly into the regression model may therefore lead to problems such as overadjustment or complete separation, making the estimates unstable or difficult to interpret. A more appropriate strategy would be to restrict the analysis to an age window where both exposed and unexposed children with and without the outcome are observed or.. Response #6: We have clarified that age was included as a covariate because it can act as a common cause influencing both chemical exposure and pubertal status. Excluding age from the model would have introduced residual confounding, although the potential multicollinearity between the covariates. Given that pubertal status was assessed using Tanner staging, it was not feasible to apply age-standardized measures in our study (Lines 139-140, p.6). Comment #1: Effects of background factors and other issues were difficult to control even in single- and joint-exposure analyses performed in the current study. It’s another limitation which should be clarified. Actually there are so many limitations in the current study. Response #1: We agree that unmeasured or residual confounding attributed to background factors is an important limitation. Unmeasured environmental, nutritional, or genetic factors may remain as a source of residual confounding effects. We have clarified these limitations in the revised manuscript to ensure balanced interpretation of our findings (Lines 306-310, p.16). Comment #2: "Our findings contribute to the growing body of evidence implicating environmental chemicals that have lifelong health impacts on pubertal development." The current study did not focus on all the environmental chemicals so it should be recommended not to say environmental chemicals rather sharing in a more specific way regarding heavy metals and other chemicals included in the study. Longitudinal study should be needed to say the lifelong impact. Response #2: We appreciate the reviewer’s comment. The conclusion has been revised to specify the chemical classes studied: “Our findings contribute to the growing body of evidence implicating the potential role of heavy metals, BPA and phthalate metabolites in pubertal development.” (Lines 335-336, p.17). Comment: The author has addressed the reviewers' comments, implemented appropriate revisions, and incorporated additional content that enhances the overall completeness and scholarly rigor of the manuscript. The study demonstrates a degree of innovation and holds academic significance within the relevant field. It is therefore recommended for acceptance. Response: We appreciate the reviewer’s comment. Using data from the Korea Environmental Exposure and Health Survey in Children and Adolescents, the authors conducted a cross-sectional study to look at the associations between exposure to heavy metals, bisphenol A, and phthalates and precocious or delayed puberty. The authors reported that a higher mono-benzyl phthalate concentration was associated with a higher risk of delayed puberty in girls in single-exposure models, concluding that exposure to environmental chemicals may contribute to delayed puberty. Overall, if the research questions examined in this study were to be replicated in numerous robust studies, the findings could inform public health interventions aimed at reducing the impact of modifiable environmental pollutants on puberty. With that in mind, this reviewer has the following to remark: Comment #1: The authors have made substantial modifications to their manuscript, improving clarity and overall quality. This is evident from the detailed feedback provided by the editor and reviewers. Response #1: We appreciate the reviewer’s comment. Comment #2: However, a major concern with this study is statistical power. When interpreting the results, it’s crucial to assess whether statistical power was sufficient to detect at least moderate-effect sizes to answer the research questions raised. While the authors, as recommended by the editor, have acknowledged the potential risks of overfitting and unstable estimates in their multi-exposure model, the paper could guide future studies on how to proceed. In their discussion section, the authors could suggest strategies, apart from increasing the sample size (which is a given), to improve the likelihood of detecting a true effect, if one exists. I hope this review is helpful and wish the authors the very best with their research! Response #2: We agree that the subgroup sizes were small, especially for boys with precocious puberty and girls with delayed puberty. We have explicitly acknowledged the limited power (60%) of our study in Discussion. We emphasized that the study is exploratory, aiming to provide effect-size estimates to inform future longitudinal or pooled analyses (Lines 300-301; 303-305, p.16). Submitted filename: Rebuttal letter_R2.docx 9 Dec 2025 Exposure to heavy metals, bisphenol A, and phthalates: Implications for precocious or delayed puberty PONE-D-25-12742R3 Dear Dr. Ha, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Li Yang, M.D. Academic Editor PLOS One Additional Editor Comments (optional): Thanks for the authors' efforts to comprehensively improve your manuscript according to editor's and reviewers' comments. I am pleased to inform you that your paper can be accepted for publication now. Thanks for the chance to assess your important work. Additionally, many thanks for all the reviewers' precious inputs. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #4: All comments have been addressed Reviewer #7: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Yes Reviewer #7: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: Yes Reviewer #7: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes Reviewer #7: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes Reviewer #7: (No Response) ********** Reviewer #4: (No Response) Reviewer #7: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: Yes: Mohammad Aghaali Reviewer #7: Yes: Dr. Widad Akreyi ********** PONE-D-25-12742R3 PLOS One Dear Dr. Ha, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Li Yang Academic Editor PLOS One